tiprankstipranks
Trending News
More News >
Lepu Biopharma Co. Ltd. Class H (HK:2157)
:2157
Hong Kong Market

Compare Lepu Biopharma Co. Ltd. Class H (2157) vs. Competitors

Compare
4 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Lepu Biopharma Co. Ltd. Class H
HK$4.98
HK$9.20B
-43.25
70.70%
Ascletis Pharma, Inc.
HK$12.33
HK$13.14B
-47.65
240.74%
1 Buy
0 Hold
0 Sell
Moderate Buy
Keymed Biosciences, Inc.
HK$62.80
HK$16.21B
-54.55
88.64%
3 Buy
0 Hold
0 Sell
Strong Buy
CARsgen Therapeutics Holdings Ltd.
HK$14.89
HK$9.19B
-15.58
53.77%
1 Buy
0 Hold
0 Sell
Moderate Buy
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
HK$28.70
HK$18.65B
122.12
457.56%
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H
HK$6.15
HK$3.94B
-5.62
-12.21%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:2157
Lepu Biopharma Co. Ltd. Class H
4.66
1.77
61.25%
HK:1672
Ascletis Pharma, Inc.
13.80
9.79
244.14%
HK:2162
Keymed Biosciences, Inc.
55.65
26.50
90.91%
HK:2171
CARsgen Therapeutics Holdings Ltd.
15.50
5.42
53.77%
HK:2315
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
43.88
35.97
454.74%
HK:1541
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H
4.53
-0.49
-9.76%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts